Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

Betting on biogenerics

Nature Reviews Drug Discovery volume 3, pages 197–198 (2004)Cite this article

The size of the small-molecule generic market runs into billions of dollars, and pharmaceutical companies go to great lengths to protect patents near the end of their lives. Although biologic patent expiries offer similar revenue opportunities, this is a totally different marketplace.

Patent expiry

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: Executive perceptions regarding timing of biogeneric market entry.
Figure 3: Sales of insulins and human growth hormones (key marketed brands).

References

  1. Wood Mackenzie forecast (2004).

Download references

Author information

Authors and Affiliations

  1. a pharmaceuticals and biotechnology consultant at Wood Mackenzie Ltd, Tower 42, International Finance Centre, 25 Old Broad Street, London, EC2N 1HN, UK

    Suzanne Griffiths Ph.D.

Authors
  1. Suzanne Griffiths Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

FURTHER INFORMATION

Center for Biologics Evaluation and Research

Center for Drug Evaluation and Research

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griffiths, S. Betting on biogenerics. Nat Rev Drug Discov 3, 197–198 (2004). https://doi.org/10.1038/nrd1333

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1333

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing